Caris Life Sciences Launches IPO Roadshow

Caris Life Sciences Launches IPO Roadshow

Caris Life Sciences has initiated the roadshow for its initial public offering, aiming to list on Nasdaq under the ticker 'CAI'.

Caris Life Sciences has launched the roadshow for its proposed initial public offering (IPO) of common stock, announced in a press release. The company plans to offer 23,529,412 shares, with an additional option for underwriters to purchase up to 3,529,411 more shares. The IPO price is expected to range between $16.00 and $18.00 per share.

Caris has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission and intends to list its common stock on the Nasdaq Global Select Market under the ticker symbol "CAI." BofA Securities, J.P. Morgan, and Goldman Sachs & Co. LLC are among the lead book-running managers for the offering, with Citigroup also participating as a book-running manager.

The IPO will be conducted through a prospectus, and the registration statement has been filed but is not yet effective. This marks a significant step for Caris, a company known for its advancements in precision medicine and AI-driven molecular profiling.

We hope you enjoyed this article.

Consider subscribing to one of several newsletters we publish like AI Funding Brief.

Also, consider following us on social media:

AI Funding News
AI Brief (X)

More from: Funding

Subscribe to AI Funding Brief

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like